Correlation between serum content of the main COPs (cholesterol oxidation products) from autoxidation and cardiovascular risk factors

Nutricion Hospitalaria

Volumn 26, Issue 1, 2011, Pages 144-151

  Menendez Carreno M ^a   Varo, N ^b   Mugueta, C ^b   Restituto, P ^b   Ansorena, D ^a   Astiasaran I ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Atherosclerosis; Diabetes; GC MS; Hypertension; Hypertriglyceridemia; Obesity; Oxidation

Indexed keywords

CHOLESTEROL; DRUG DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; OBESITY; OXIDATION REDUCTION REACTION; RISK FACTOR;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OVERWEIGHT; OXIDATION-REDUCTION; RISK FACTORS; TRIGLYCERIDES;

EID: 79952969257     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.1.4690     Document Type: Article

References (51)

1. Schroepfer GJ. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol Rev 2000; 80 (1): 361-554.
2. Guardiola F, Tres A, Codony R, Addis PB, Bergmann SD, Zavoral JH. Lack of effect of oral supplementation with antioxidants on cholesterol oxidation product concentration of human plasma, as revealed by an improved gas chromatography method. Anal Bioanal Chem 2007; 389: 277-289. (Pubitemid 47325231)
3. Menéndez-Carreño M, Ansorena D, Milagro FI, Campión J, Martínez JA, Astiasarán I. Inhibition of serum cholesterol oxidation by dietary vitamin C and selenium intake in high fat fed rats. Lipids 2008; 43: 383-390.
4. Sottero B, Gamba P, Gargiulo S, Leonarduzzi S, Poli G. Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry. Curr Med Chem 2009; 16 (6): 685-705.
5. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999; 142: 1-28. (Pubitemid 28553934)
6. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006; 13 (3): 129-142.
7. Guardiola F, Codony R, Addis PB, Rafecas M, Boatella J. Biological effects of oxysterols: Current status. Food Chem Toxicol 1996; 34 (2): 193-211. (Pubitemid 26076847)
8. Leonarduzzi G, Sottero B, Poli G. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). J Nutr Biochem 2002; 13: 700-710. (Pubitemid 35463198)
9. Stocker R, Keaney JF Jr. Role of Oxidative Modifications in Atherosclerosis. Physiol Rev 2004; 84: 1381-1478. (Pubitemid 39302636)
10. Zhou Q, Wasowicz E, Handler B, Fleischer L, Kummerow FA. An excess concentration of oxysterols in the plasma is cytotoxic to cultures endothelial cells. Atherosclerosis 2000; 149: 191-197. (Pubitemid 30125988)
11. Larsson DA, Baird S, Nyhalah JD, Yuan XM, Li W. Oxysterols mixtures, in atheroma-relevant prportions, display synergistic and proapoptotic effects. Free Rad Biol Med 2006; 41: 902-910. (Pubitemid 44247546)
12. Abo K, Mio T, Sumino K. Comparative analysis of plasma and erythrocyte 7-ketocholesterol as a marker for oxidative stresss in patients with diabetes mellitus. Clin Biochem 2000; 33 (7): 541-547. (Pubitemid 32011862)
13. Arca M, Natoli S, Micheletta F, Riggi S, Di Angelantonio E, Montli A, Antonini MT, Antonini R, Diczfalusy U, Iuliano L. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: Reduction during atorvastatin and fenofibrate therapy. Free Rad Biol Med 2007; 42: 698-705. (Pubitemid 46205153)
14. Murakami H, Tamasawa N, Matsui J, Yamato K, JingZhi G, Suda S. Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation products in type 2 diabetic patients with nephropathy. J Atheroscl Thromb 2002; 8 (1): 21-24.
15. Szuchman A, Aviram M, Musa R, Khatib S, Vaya J. Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker. Biomarkers 2008; 13 (1): 119-131.
16. Zwirska-Korczala K, Jagodzinska J, Wielkoszynski T, Jochem J, Bodzek D, Wylezol M, Pardela M. Assessment of plasma lipid profile oxysterols and vitamin E concentration in morbidity obese patients with coexisting arterial hypertension and non-insulin dependent diabetes mellitus. Pol Arch Med Wewn 2002; 107 (2): 141-147.
17. Alkazemi D, Egeland G, Vaya J, Meltzer S, Kubow S. Oxysterol as a marker of atherogenic dyslipemia in adolescence. J Clin Endocrinol Metabol 2008; 93 (11): 4282-4289. (Pubitemid 352789523)
18. Griffiths WJ, Wang Y. Sterol lipidomics in health and disease: Methodologies and applications. Eur J Lipid Sci Technol 2009; 111: 14-38.
19. National Cholesterol Education Program's Adult Treatment Panel III: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002; 106: 3143-3441.
20. Menéndez-Carreño M, García-Herreros C, Astiasarán I, Ansorena D. Validation of a gas chromatography-mass spectrometry method for the analysis of sterol oxidation products in serum. J Chromat B 2008; 864: 61-68.
21. Rozner S, Garti N. The activity and absorption relationship of cholesterol and phytosterols. Colloids Surfaces A: Physicochem Eng Aspects 2006; 82, 283: 435-456. (Pubitemid 43816829)
22. Sevanian A, Hodis HN, Hwang J, Peterson H. In: Bellomo G, Finardi G, Maggi E, Rice Evans C (eds). Free radicals, lipoprotein oxidation and atherosclerosis. Richelieu, London, 1995, pp. 139-161.
23. Micheletta F, Natoli S, Misuraca M, Sbarigia E, Diczfalusy U, Iuliano L. Vitamin e supplementation in patients with carotid atherosclerosis -Reversal of altered oxidative stress status in plasma but not in plaque. Arterioscler Thromb Vasc Biol 2004; 24 (1): 136-140. (Pubitemid 38082424)
24. JNC VI: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446.
25. Gavin III JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, Genuth S, Harris MI, Kahn R, Keen H, Knowler WC, Lebovizt H, Maclaren JK, Palmer JP, Raksin P, Rizza RA, Stern MP. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 (Suppl.):S5-S19. (Pubitemid 28040139)
26. National Institutes of Health: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998; (6 Suppl.): 51S-209S.
27. Crosignani A, Del Puppo M, De Fabiani E, Caruso, Gallisai D, Mela MG, Melzi M, Galli Kienle M, Colombo C. Plasma oxysterols in normal and cholestatic children as indicators of the two pathways of bile acid synthesis. Clin Chim Acta 2008; 395: 84-88.
28. Smith L. Cholesterol autoxidation 1981-1987. Chem Phys Lipids 1997; 44: 87-125.
29. Diczfalusy U. Oxysterols in biological samples. In Cholesterol and phytosterol oxidation products: analysis, occurrence, and biological effects. Ed. Guardiola F, Dutta P, Codony R, Savage GP. AOCS Press. 2002, pp. 204-240.
30. Diczfalusy U, Olofsson KE, Carlsson AM, Gong M, Golenbock DT, Rooyackers O, Flaring U, Bjorkbacka H. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J Lipids Res 2009; 50: 2258-2264.
31. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silberhatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 88: 1837-47. (Pubitemid 28213628)
32. Stamler J, Wentworth D, Neaton JD, for the MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease using continuous and graded. Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). J Am Med Assoc 1986; 256: 2823-2838.
33. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I: Reduction in the incidence of coronary heart disease. JAMA 25: 351-364.
34. Iuliano L, Micheletta F, Natoli S, Ginanni-Corradini S, Iappelli M, Elisei W, Giovannelli L, Violi F, Diczfalusy U. Measurement of oxysterols and á-tocopherol in plasma and tissues samples as indices of oxidant stress status. Anal Biochem 2003; 312: 217-223. (Pubitemid 36151134)
35. Rimner A, Al Makdessi S, Sweidan H, Wischhusen J, Rabenstein B, Shatat K, Spyridopoulos I. Relevance and mechanism of oxysterol stereospecifity in coronay artery disease. Free Rad Bio Med 200; 535: 535-544.
36. Prunet C, Petit JM, Ecarnot-Laubriet A, Athias A, Miguet-Afonsi C, Rohmer JF, Steinmetz E, Néel D, Lizard G. High circulating levels of 7â-and 7á-hydroxycholesterol and presence of apoptotic and oxidative markers in arterial lesions of normocholesterolemic atherosclerotic patients undergoing endarterectomy. Pathol Biol 2006; 54: 22-32. (Pubitemid 43014764)
37. Toikka JO, Ahotupa M, Viikari JSA, Niinikoski H, Taskinen MR, Irjala K, Hartiala JJ, Raitakari OT. Constantly low HDLcholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis 1999; 147: 133-138. (Pubitemid 29486782)
38. Tall AR. Cholesterol efflux pathways and other potential mechanism involved in the athero-protective effect of high density lipoproteins. J Intern Med 2008; 263: 256-273. (Pubitemid 351207349)
39. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81: 7B-12B. (Pubitemid 28113939)
40. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology a a guide of clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1998; 302: 1383-1389.
41. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbot R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease: part 1: prolonged differences dilution bias. Lancet 1990; 335: 765-774.
42. Deckert V, Brunet A, Lantoine F, Lizard G, Millanvoye-van Brussel E, Monier S, Larost L, David-Dufilho M, Gambert P, Devynk MA. Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. Arterioscl Thromb Vasc Biol 1998; 18: 1054-1060. (Pubitemid 28323589)
43. Moriel P, Sevanian A, Ajzen S, Zanella MT, Plavnik FL, Rubbo H, Abdalla DSP: Nitric oxide, cholesterol oxides and endothelium-dependent vasodilation in plasma of patients with essential hypertension. Braz J Med Biol Res 2002; 35: 1301-1309. (Pubitemid 36013580)
44. Hodis HN, Hashimoto S, Mack WJ, Sevanian A. Probucol reduces oxysterol formation in hypertensive rabbits. Free Rad Biol Med 2000; 25: 621-628.
45. Bierman EL. George Lyman Duff Memorial Lecture. Arteriosclerosis Thrombosis 1992; 12: 647-656.
46. Ferderbar S, Pereira EC, Apolinário E, Bertolami MC, Faludi A, Monte O, Calliari LE, Sales JE, Gagliardi AR, Xavier HT, Abdalla DSP. Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews 2007; 23: 35-42. (Pubitemid 46152484)
47. Endo K, Oyama T, Saiki A, Ohira M, Koide N, Murano T, Watanabe H, Nishii M, Miura M, Sekine K, Miyashita Y, Shirai K. Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus. Diab Res Clin Pract 2008; 80: 63-68.
48. Yoshioka N, Adachi J, Ueno Y, Yoshida K. Oxysterol increased in diabetic rats. Free Rad Res 2005; 39 (3): 299-304.
49. Calle EE, Thun MJ, Petrelli JM, Rodríguez C, Heath CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105. (Pubitemid 29466221)
50. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114 (12): 1752-1761. (Pubitemid 40385531)
51. Njajou OT, Kanaya AM, Holvoet P, Connelly S, Strotmeyer ES, Harris TB, Cummings SR, Hsueh WC. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diab Metab Res Rev 2009; 25 (8): 733-739.